{
  "actions": [
    {
      "acted_at": "2013-08-02", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2013-08-02", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-08-02", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3005-113", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "bioguide_id": "B001285", 
      "district": "26", 
      "name": "Brownley, Julia", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-10-07", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "E000215", 
      "district": "18", 
      "name": "Eshoo, Anna G.", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-09-18", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "G000377", 
      "district": "12", 
      "name": "Granger, Kay", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-09-26", 
      "state": "TX", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "H001038", 
      "district": "26", 
      "name": "Higgins, Brian", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-09-26", 
      "state": "NY", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "H001034", 
      "district": "17", 
      "name": "Honda, Michael M.", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-09-10", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "P000608", 
      "district": "52", 
      "name": "Peters, Scott H.", 
      "original_cosponsor": false, 
      "sponsored_at": "2013-11-18", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S001175", 
      "district": "14", 
      "name": "Speier, Jackie", 
      "original_cosponsor": true, 
      "sponsored_at": "2013-08-02", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2013-08-02", 
  "number": "3005", 
  "official_title": "To amend chapter V of the Federal Food, Drug, and Cosmetic Act to permit the sale of, and access to, \"research use only\" products in diagnostic tests.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medical Testing Availability Act of 2013", 
  "sponsor": {
    "bioguide_id": "B001248", 
    "district": "26", 
    "name": "Burgess, Michael C.", 
    "state": "TX", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2013-08-02", 
  "subjects": [
    "Consumer affairs", 
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Health technology, devices, supplies", 
    "Medical research", 
    "Product safety and quality"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2013-08-02T04:00:00Z", 
    "text": "Medical Testing Availability Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act with respect to labeling in the shipment or delivery of an in vitro diagnostic product for an investigation exempt from compliance with a performance standard or the requirement of premarket approval.\n\nDeclares that such a product whose labeling states \"For Research Use Only. Not for use in diagnostic procedures.\" may not be deemed misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product in a manner inconsistent with such statement, or (2) engages in business communications regarding the product with an end user.\n\nDefines \"business communications\": (1) as oral, written, or electronic contact between a manufacturer or distributor of such a product and an end user regarding the product's functioning; and (2) includes any such contact consisting of technical support, customer service, assistance with the installation of such product, communication relating to ensuring the performance of the product, and other similar contacts."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Medical Testing Availability Act of 2013", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend chapter V of the Federal Food, Drug, and Cosmetic Act to permit the sale of, and access to, \"research use only\" products in diagnostic tests.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Medical Testing Availability Act of 2013", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-10-25T16:06:54Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/113/hr/BILLSTATUS-113hr3005.xml"
}